Literature DB >> 17891353

Acute renal failure due to interstitial nephritis after intravesical instillation of BCG.

Maria Jose Manzanera Escribano1, Enrique Morales Ruiz2, Mónica Odriozola Grijalba1, Eduardo Gutierrez Martínez1, Alfredo Rodriguez Antolín3, Manuel Praga Terente1.   

Abstract

Intravesical chemotherapy with bacilli Calmette-Guerin (BCG) has been an established therapy for preventing recurrence of, and for treatment of, superficial transitional cell carcinoma of the bladder, but it is not without side effects. A variety of renal complications have been reported and attributed to mycobacterial infection. Although renal complications are uncommon, several cases of interstitial nephritis (with or without granulomas) and mesangial glomerulonephritis have been reported. We report a 76-year-old male patient who developed acute renal failure due to interstitial nephritis after intravesical instillation of BCG. Corticosteroids may serve the recovery of renal function without concomitant use of anti-tubercular therapy, provided systemic signs and mycobacterial infection are absent. Serum creatinine should be checked in at-risk patients in order to detect this complication early.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891353     DOI: 10.1007/s10157-007-0483-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  16 in total

Review 1.  Disseminated Mycobacterium bovis after intravesicular bacillus calmette-Gu rin treatments for bladder cancer.

Authors:  M Elkabani; J N Greene; A L Vincent; S VanHook; R L Sandin
Journal:  Cancer Control       Date:  2000 Sep-Oct       Impact factor: 3.302

2.  Acute granulomatous tubulointerstitial nephritis caused by intravesical BCG.

Authors:  Sean E Kennedy; Sivanandam Shrikanth; John A Charlesworth
Journal:  Nephrol Dial Transplant       Date:  2006-02-02       Impact factor: 5.992

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-1998. A 57-year-old man with fever and jaundice after intravesical instillation of bacille Calmette-Guérin for bladder cancer.

Authors: 
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

4.  Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trial.

Authors:  A P van der Meijden; M Brausi; V Zambon; W Kirkels; C de Balincourt; R Sylvester
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

Review 5.  Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer.

Authors:  D L Lamm
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

Review 6.  [Granulomatous interstitial nephritis with acute renal insufficiency, a potential complication of intravesicular bcg therapy].

Authors:  R Binaut; F Bridoux; F Provôt; N Daniel; D Fleury; B Mougenot; P Vanhille
Journal:  Nephrologie       Date:  1997

7.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

Review 8.  Use of bacille Calmette-Guérin in superficial bladder cancer.

Authors:  J-P Meyer; R Persad; D A Gillatt
Journal:  Postgrad Med J       Date:  2002-08       Impact factor: 2.401

9.  Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy.

Authors:  C McParland; D J Cotton; K S Gowda; V H Hoeppner; W T Martin; P F Weckworth
Journal:  Am Rev Respir Dis       Date:  1992-11

Review 10.  Renal complications of intravesical bacillus Calmette-Guérin therapy.

Authors:  A Modesto; L Marty; J M Suc; D Kleinknecht; J F de Frémont; T Marsepoil; P Veyssier
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

View more
  4 in total

1.  Mycotic aneurysm formation after bacillus Calmette-Guérin instillation for recurrent bladder cancer.

Authors:  Sagar Rohailla; Abhijat Kitchlu; Mark Wheatcroft; Fahad Razak
Journal:  CMAJ       Date:  2018-04-16       Impact factor: 8.262

2.  Complications of intravesical bacillus calmette-guérin.

Authors:  Liam C Macleod; Tin C Ngo; Mark L Gonzalgo
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

Review 3.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

Review 4.  Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer.

Authors:  Azharuddin Mohammed; Zubair Arastu
Journal:  BMC Urol       Date:  2017-12-06       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.